Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa crossover trial of inhaled LAS100977 versus placebo and indacaterol in COPD
2011-000429-58Phase 2Completed
- Sponsor
- Almirall
- Start
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of abediterol in chronic obstructive pulmonary disease (COPD) (6 arms), sponsored by Almirall. Primary endpoint: Change from baseline to through FEV1 on Day 2. Started May 2011; status: completed.
02
Drugs
abediterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2011-000429-58.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000429-58.